Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
6.52
+0.14 (2.19%)
At close: Sep 30, 2026, 4:00 PM EDT
6.38
-0.14 (-2.15%)
Pre-market: Oct 1, 2026, 7:30 AM EDT
Aethlon Medical Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
9
Market Cap
4.64M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | - | - | - |
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | 574.25K | 280.08K | 95.21% |
| Mar 31, 2022 | 294.17K | -364.94K | -55.37% |
| Mar 31, 2021 | 659.10K | 8.92K | 1.37% |
| Mar 31, 2020 | 650.19K | 420.56K | 183.15% |
| Mar 31, 2019 | 229.63K | 80.00K | 53.47% |
| Mar 31, 2018 | 149.63K | -242.45K | -61.84% |
| Mar 31, 2017 | 392.07K | -494.50K | -55.78% |
| Mar 31, 2016 | 886.57K | 124.16K | 16.28% |
| Mar 31, 2015 | 762.42K | -861.35K | -53.05% |
| Mar 31, 2014 | 1.62M | 393.77K | 32.01% |
| Mar 31, 2013 | 1.23M | -129.62K | -9.53% |
| Mar 31, 2012 | 1.36M | - | - |
| Mar 31, 2011 | - | - | - |
| Mar 31, 2010 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Trinity Biotech | 43.79M |
| WORK Medical Technology Group LTD | 10.72M |
| INVO Fertility | 7.53M |
| Intelligent Bio Solutions | 4.22M |
| VolitionRx | 2.46M |
| 20/20 Biolabs | 2.04M |
| Adagio Medical Holdings | 137.00K |
| Phaos Technology Holdings (Cayman) Limited | 103.68K |
AEMD News
- 13 days ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruger & Company, Inc. (NYSE – RGR), Atkore, Inc. (NYSE – ATKR), Centerspace (NYSE – CSR), Aethlon Medical, Inc. (Nasdaq – AEMD) - GlobeNewsWire
- 13 days ago - M&A News: Aethlon Medical Stock (AEMD) Rockets 400% After North Immunology Deal to Fight Eczema - TipRanks
- 14 days ago - Aethlon Medical, North Immunology enter all-stock transaction - TheFly
- 14 days ago - Aethlon Medical & North Immunology Announce Merger to Advance Novel IL-13 x IL-18 Bispecific Antibody for Atopic Dermatitis - PRNewsWire
- 27 days ago - Aethlon Medical Proxy statement: Proxy filing - Filings
- 4 weeks ago - Aethlon Medical Proxy statement: Proxy filing - Filings
- 5 weeks ago - Aethlon Medical Proxy statement: Proxy filing - Filings
- 6 weeks ago - Aethlon Medical Transcript: Emerging Growth Conference - Transcripts